✦ LIBER ✦

Randomized, Multicenter, Open-Label Phase II Study of Gemcitabine plus Single-Dose Versus Split-Dose Carboplatin in the Treatment of Patients with Advanced-Stage Non-Small-Cell Lung Cancer

✍ Scribed by Wolfgang Schuette; Thomas Blankenburg; Claus-Peter Schneider; Ludwig Fischer von Weikersthal; Sylvia Guetz; Gerhard Laier-Groeneveld; Johann Christian Virchow; Assnad Chemaissani; Martin Reck

Book ID: 115076639
Publisher: CIG Media Group, LP.
Year: 2006
Tongue: English
Weight: 142 KB
Volume: 8
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2006.n.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, multicenter, phase II study

Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer

✍ Mazzanti, Paola; Massacesi, Cristian; Rocchi, Marco B.L.; Mattioli, Rodolfo; Lip 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Vinorelbine plus gemcitabine followed by

Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study

✍ Kaoru Kubota; Masaaki Kawahara; Mitsumasa Ogawara; Yutaka Nishiwaki; Kiyoshi Kom 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 173 KB

Gemcitabine and low dose carboplatin in

Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer

✍ Maestu, I 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Docetaxel versus docetaxel plus gemcitab

Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial

✍ Georgoulias, Vassilis; Androulakis, Nikolaos; Kotsakis, Athanasios; Hatzidaki, D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Open, Randomized, Phase II Study of Sing

Open, Randomized, Phase II Study of Single-Agent Gemcitabine and Docetaxel as First- and Second-Line Treatment in Patients with Advanced Non–Small-Cell Lung Cancer

✍ Christian Manegold; Gabriele Koschel; Dagmar Hruska; Kathrin Schott-von-Römer; J 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 155 KB

A phase II randomized trial of gemcitabi

A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma

✍ Joaquín Casal Rubio; S. Vázquez; F. Vázquez; M. Amenedo; J. L. Fírvida; J. R. Me 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 255 KB